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Embryonic  stem  cells  in  the  blastocyst  stage 
have the potential to generate any terminally 
differentiated cells in the body; however, other 
adult stem cell types, including hematopoietic 
stem cells/progenitor cells (HSCs/HPCs), have 
limited  potency  for  postnatal  tissue/organ 
regeneration. The hematopoietic system has 
traditionally been considered unique among 
phenotypically  characterized  adult  stem/pro-
genitor cells (Slack, 2000; Blau et al., 2001; 
Korbling and Estrov, 2003) in that it is an orga-
nized,  hierarchical  system  with  multipotent, 
self-renewing stem cells at the top, lineage-
committed progenitor cells in the middle, and   
lineage-restricted precursor cells, which give rise   
to terminally differentiated cells, at the bottom 
(Weissman,  2000).  Recently,  Takaki  et  al. 
(2002) reported that Lnk is expressed in hema-
topoietic cell lineages, and BM cells of Lnk-
deficient  mice  are  competitively  superior  in 
hematopoietic population to those of WT mice. 
They also clarified that not only HSC/HPC 
numbers but also the self-renewal capacity of 
some HSCs/HPCs were markedly increased in 
Lnk-deficient mice (Ema et al., 2005). In addi-
tion, they identified the functional domains of 
Lnk and developed a dominant-negative Lnk 
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The therapeutic potential of hematopoietic stem cells/endothelial progenitor cells (HSCs/
EPCs) for fracture healing has been demonstrated with evidence for enhanced vasculogenesis/
angiogenesis and osteogenesis at the site of fracture. The adaptor protein Lnk has recently 
been identified as an essential inhibitor of stem cell factor (SCF)–cKit signaling during 
stem cell self-renewal, and Lnk-deficient mice demonstrate enhanced hematopoietic recon-
stitution. In this study, we investigated whether the loss of Lnk signaling enhances the 
regenerative response during fracture healing. Radiological and histological examination 
showed accelerated fracture healing and remodeling in Lnk-deficient mice compared with 
wild-type mice. Molecular, physiological, and morphological approaches showed that vascu-
logenesis/angiogenesis and osteogenesis were promoted in Lnk-deficient mice by the mobi-
lization and recruitment of HSCs/EPCs via activation of the SCF–cKit signaling pathway in 
the perifracture zone, which established a favorable environment for bone healing and 
remodeling. In addition, osteoblasts (OBs) from Lnk-deficient mice had a greater potential 
for terminal differentiation in response to SCF–cKit signaling in vitro. These findings sug-
gest that inhibition of Lnk may have therapeutic potential by promoting an environment 
conducive to vasculogenesis/angiogenesis and osteogenesis and by facilitating OB terminal 
differentiation, leading to enhanced fracture healing.
© 2010 Matsumoto et al.  This article is distributed under the terms of an At-
tribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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by HSC/EPC mobilization and recruitment to sites of frac-
ture in Lnk-deficient mice. In our series of experiments, we 
showed that a negatively controlled Lnk system contributed 
to a favorable environment for fracture healing by enhancing 
vasculogenesis/angiogenesis and osteogenesis via activation of 
SCF–cKit signaling pathway, which leads to prompt recovery 
from fracture. In contrast, cKit expression was observed in 
several tissues and cells, including OBs (Bilbe et al., 1996).
This is the first study showing interaction between the 
Lnk system and fracture healing that provides a new insight 
into negatively controlling the Lnk system not only to pro-
mote an environment conducive to vasculogenesis/angio-
genesis and osteogenesis but also to up-regulate the potential 
of OB terminal differentiation so that fractures can promptly 
heal. Therefore, negatively regulating the Lnk system has im-
portant implications for the formulation of new therapeutic 
strategies to enhance bone repair.
RESULTS
Pre- and post-fracture phenotypic characterization  
of BM and PB
We first attempted to compare the frequency of BM HSC/
EPC fraction identified as cKit+SL (KSL) cells at pre-fracture 
and 7 d after fracture in Lnk KO mice and age-matched WT 
mice (C57BL/6). The percentage of BM KSL fraction was 
significantly higher in post-fracture bone than in pre-fracture 
bone, regardless of mouse phenotype; however, it was signif-
icantly high in both pre- and post-fracture bone in Lnk KO 
mice compared with WT mice (pre-fracture: Lnk KO, 19.3 ± 
0.5, WT, 5.6 ± 0.2; post-fracture: Lnk KO, 23.7 ± 0.5, WT, 
8.3 ± 0.4%, respectively; P < 0.05 for Lnk KO vs. WT in 
both pre- and post-fracture bone; pre- vs. post-fracture bone 
in both Lnk KO and WT; n = 5; Fig. 1 a). Also, the number 
of KSL cells in 105 of PB mononuclear cells (MNCs) was sig-
nificantly greater in post-fracture bone than in pre-fracture 
bone, regardless of mouse phenotype, and it was significantly 
great in both pre- and post-fracture PB in Lnk KO mice com-
pared with WT mice (prefracture: Lnk KO, 1,141.4 ± 192.0; 
WT, 581.9 ± 97.7, post-fracture: Lnk KO, 1,467.1 ± 235.2; 
WT, 941.9 ± 300.0, respectively; P < 0.01 for Lnk KO vs. 
WT in both pre- and post-fracture; P < 0.05 for pre- vs. 
post-fracture in both Lnk KO and WT; n = 5; Fig. 1 b).
We next investigated which cell populations were mobi-
lized into PB under fracture stress. Because the KSL cell pop-
ulation is extremely small in PB, there was no significant 
difference between the number and the percentage in PB at pre-
fracture and 7 d post-fracture (unpublished data). We there-
fore attempted to make a comparison of the frequency of PB 
HSC/EPC-enriched fraction identified as cells at prefracture, 
1, 4, 7, and 14 d after fracture in Lnk KO and WT mice. The 
percentage of post-fracture HSC/EPC-enriched fraction in 
PB was significantly higher, peaking at day 1 in both Lnk KO 
and WT mice, than that of pre-fracture (pre-fracture: Lnk KO, 
39.7 ± 3.1, WT, 44.9 ± 0.8; 1 d post-fracture: Lnk KO, 56.2 ± 
1.6, WT, 59.3 ± 3.1; 4 d post-fracture: Lnk KO, 53.5 ± 3.0, 
WT, 57.7 ± 1.1; 7 d post-fracture: Lnk KO, 43.8 ± 4.1, WT, 
mutant that inhibits the functions of Lnk that are endoge-
nously expressed in the HSCs/HPCs and thereby potentiates 
the HPCs for engraftment (Takizawa et al., 2006). Lnk shares 
a pleckstrin homology domain, a Src homology 2 domain, 
and potential tyrosine phosphorylation sites with APS and 
SH-2B. It belongs to a family of adaptor proteins implicated 
in integration and regulation of multiple signaling events (Huang 
et al., 1995; Takaki et al., 1997; Yokouchi et al., 1997; Li et al., 
2000; Ahmed and Pillay, 2003) and has also been suggested 
to act as a negative regulator in the stem cell factor (SCF)–
c-Kit signaling pathway (Takaki et al., 2000, 2002).
In another category of regenerative medicine, bone for-
mation and regeneration has been extensively researched to 
meet clinical demand. A biologically optimal process of frac-
ture repair results in the restoration of normal structure and 
function in the injured skeletal tissue. Although most frac-
tures heal within a certain time period with callus formation 
that bridges the fracture gap while bone repair takes place, a 
large number of patients with fractures lose valuable time 
because of disability or confinement, leading to a loss of pro-
ductivity and income. Moreover, a significant amount (5–10%) 
of fractures fail to heal and result in delayed union or persis-
tent nonunion (Marsh, 1998; Rodriguez-Merchan and Forriol, 
2004). Among various causes of failed bone formation and 
remodeling, inappropriate neoangiogenesis is considered to 
be a crucial factor (Harper and Kalgsbrun, 1999; Colnot   
and Helms, 2001). Notably, appropriate vasculogenesis by BM 
endothelial progenitor cells (EPCs; Asahara et al., 1997) is 
emerging as a prerequisite for bone development and regen-
eration, and there appears to be a developmental reciprocity be-
tween endothelial cells (ECs) and osteoblasts (OBs; Karsenty 
and Wagner, 2002). We have recently proved a patho-
physiological  role  and  contribution  of  murine  BM-derived 
Sca1+Lin (SL) cells, HSC/EPC-enriched fraction, for bone 
healing (Matsumoto et al., 2008). Another group has also re-
ported the increase of CD34+/AC133+ cells in peripheral 
blood (PB) of patients with fracture, suggesting the contribu-
tion of PB EPCs to bone healing (Laing et al., 2007). How-
ever, previous studies have demonstrated that the majority of 
callus-formed cells in fracture were derived from the perios-
teum rather than from PB (Nakazawa et al., 2004), indicating 
a minor contribution of BM-derived cells to fracture healing. 
Moreover, periosteal cells, but not endosteal BM cells, have 
recently been shown to be competent to produce fracture callus 
(Colnot, 2009). Therefore, emerging the concept of enhanced 
osteogenesis/angiogenesis by HSCs/EPCs, one of the novel 
factors responsible for stem/progenitor cell mobilization from 
BM, that is Lnk, attracted our research interests to develop 
therapeutic strategy using circulating EPCs for bone fracture.
SCF has already been reported to stimulate proliferation 
and differentiation of HSCs (Broudy, 1997) and mobilize 
HSCs/EPCs into PB (Mauch et al., 1995; Takahashi et al., 
1999) by binding with cKit. Thus, we have investigated the 
hypothesis that a lack of Lnk signaling, dependent on the 
SCF–cKit signaling pathway, enhanced the regenerative re-
sponse via vasculogenesis and osteogenesis in fracture healing JEM VOL. 207, September 27, 2010 
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KO-BMT  Lnk  KO  mice,  whereas  the  double-positive 
cells were rarely identified in Tie2/LacZ WT-BMT WT 
mice (Fig. 2 a). The number of double-positive cells was sig-
nificantly increased in Tie2/LacZ Lnk KO-BMT Lnk KO 
mice compared with that in Tie2/LacZ WT-BMT WT mice 
(Lnk KO, 410.0 ± 37.6 vs. WT, 230.0 ± 56.7/mm2; P < 0.05; 
n = 3; Fig. 2 b). The -gal+ and OC double-positive OBs 
were frequently observed as lining cells along with newly 
formed bone surface in Tie2/LacZ Lnk KO-BMT Lnk KO 
mice, whereas only a few double-positive cells were identi-
fied in Tie2/LacZ WT-BMT WT mice. (Fig. 2 a) The num-
ber  of  double-positive  cells  was  significantly  increased  in 
Tie2/LacZ Lnk KO-BMT Lnk KO mice compared with 
that in Tie2/LacZ WT-BMT WT mice (Lnk KO, 195.0 ± 
31.0 vs.WT, 105.0 ± 21.5/mm2; P < 0.05; n = 3; Fig. 2 c). 
These results suggest that enhanced recruitment of mobilized 
Tie2+ stem/progenitor cells to fracture sites contributes to 
vasculogenesis and osteogenesis, leading to accelerated frac-
ture healing in Lnk KO mice.
BM-derived SL cells exhibit multilineage differentiation 
potential in vitro
To explore whether SL cells have multilineage differentiation 
potential, specifically to ECs, OBs, and adipocytes (ADs), 
BM-derived SL cells were cultured in differentiation induc-
tion medium for each lineage, and each marker expression was 
examined by real-time RT-PCR and immunocytochemistry 
after culture for 7 and 14 d, respectively. The mRNA expres-
sion of EC markers (CD31: 243.8 ± 7.3 vs. 372.1 ± 7.0, P < 
0.05, n = 3; vWF: 49.1 ± 1.0 vs. 396.0 ± 24.1, P < 0.01, n = 3;   
Fig. 2 d), OB markers (OC: 6.7 ± 0.8 vs. 182.6 ± 9.5, P < 0.001,   
n = 3; Collagen 1-A1: 784.6 ± 107.8 vs. 22,667 ± 2,114,   
P < 0.001, n = 3; Fig. 2 e), and AD markers (LPL: 1.4 ± 0.1 
vs. 642.0 ± 17.2, P < 0.0001, n = 3; PPAR: 7.1 ± 0.3 vs. 
162.7 ± 6.7, P < 0.0001, n = 3; Fig. 2 f) were significantly 
up-regulated by culture with each lineage induction medium. 
These lineage marker expressions were further confirmed by 
55.0 ± 1.2; 14 d post-fracture: Lnk KO, 41.0 ± 1.9, WT, 
52.6 ± 2.4%; P < 0.01 for pre-fracture vs. 1 d post-fracture 
in both Lnk KO and WT; P < 0.05 for pre-fracture vs. 4 d 
post-fracture in both Lnk KO and WT; n = 5). The number 
of post-fracture SL cells per 1 ml of PB was significantly high, 
peaking at day 1 compared with pre-fracture (pre-fracture: 
Lnk KO, 15.1 ± 1.0, WT, 7.2 ± 1.1; 1 d post-fracture: Lnk 
KO, 35.6 ± 3.7, WT, 22.1 ± 6.1; 4 d post-fracture: Lnk KO, 
29.5 ± 2.8, WT, 15.6 ± 9.7; 7 d post-fracture: Lnk KO, 25.3 ± 
5.4, WT, 13.7 ± 1.9; 14 d post-fracture: Lnk KO, 24.8 ± 5.4, 
WT, 8.4 ± 1.9 × 104 cells/ml; P < 0.01 for pre-fracture vs.   
1 d post-fracture in both Lnk KO and WT; P < 0.05 for pre-
fracture vs. 4 d post-fracture in both Lnk KO and WT, Lnk 
KO vs. WT at each time point; n = 5; Fig. 1 c). These results 
indicate that both fracture stress and lack of Lnk induce the mo-
bilization of SL cells, including KSL cells from BM, resulting 
in a high SL/KSL cell number in PB in Lnk KO fractured 
mice compared with that in WT mice.
Tie2+ stem/progenitor cell contribution to vasculogenesis 
and osteogenesis
Based on the aforementioned evidence, we looked for BM-
derived Tie2+ stem/progenitor cells in sites of fracture using 
a mouse BM transplantation (BMT) model. First, we gener-
ated Tie2/LacZ Lnk KO mice, in which the LacZ gene is 
expressed under the regulation of promotor Tie2 (lacking the 
Lnk gene), by crossing Tie2/LacZ transgenic and Lnk KO 
mice. We then performed BMT from Tie2/LacZ Lnk KO 
mice to Lnk KO mice and from Tie2/LacZ WT mice to WT 
mice. Fracture was induced 4 wk after BMT, after reconsti-
tution of BM with Tie2/LacZ Lnk KO cells in Lnk KO and 
WT mice, and granulation tissue was analyzed histologically in 
sites of fracture 7 d after surgery. Double-fluorescent immuno-
staining was performed for -galactosidase (-gal), which can 
detect BM-derived Tie2+ cells and CD31, an EC marker, or 
for -gal and osteocalcin (OC). The -gal+ and CD31 double-
positive ECs were frequently observed in Tie2/LacZ Lnk 
Figure 1.  Phenotypic characterization of 
BM and PB pre- and post-fracture. (a) The 
percentage of KSL fraction in BMMNCs was 
assessed by FACS analysis at pre- and 7 d 
post-fracture (fx) stage in WT and Lnk KO 
mice, and expressed on the top right quadrant 
of the dot-blot graph. *, P < 0.05 versus WT; †, 
P < 0.05 vs. pre-fx. (b) The number of KSL cells 
in BMMNCs was also assessed by FACS at  
pre- and 7 d post-fx stage in WT (open 
square) and Lnk KO (open rhombus) mice.  
**, P < 0.01 vs. WT; †, P < 0.05 vs. pre-fx.  
(c) The number of SL cells in 1 ml of PB was 
assessed by FACS in WT (open square) and Lnk 
KO (open rhombus) mice in the indicated time 
course. ††, P < 0.01; †, P < 0.05 versus pre-fx; 
*, P < 0.05 versus WT. All data averaged from 
five independent experiments. All the mean 
values with SEM were obtained from tripli-
cated assays.2210 Lnk-dependent axis of SCF–cKit signal for osteogenesis | Matsumoto et al.
Molecular evidence of enhanced 
angiogenesis and osteogenesis  
in Lnk KO mice
To explore specific gene expression dif-
ferences  under  fracture  stress  between 
Lnk-deficient and WT mice, angiogen-
esis (96)– and osteogenesis (96)–related 
genes of the tissue at the fracture site 
spotted  on  cDNA  microarrays  were   
hybridized  with  biotin-labeled  cDNA 
probes according to the manufacturer’s 
instructions. In angiogenesis gene array, 
relative  expression  levels  of  12  genes 
(ANG,  Fisp12  [Ctgf],  VEGFR[Flt1], 
HGF, IL-10, Gelatinase B [Mmp9], SR-
A [Msr1], Restin [Rsn], BM40 [Sparc], 
ALK-5 [Tgfbr1], THBS1, and VCAM-1) 
of  Lnk-deficient  fractured  mice  in-
creased by >1.5-fold, but 5 genes (Ephrin B4 [Ephb4], IFNr [Ifng], 
NOS3, Osteopontin [Spp1], and THBS2) decreased by >2-fold 
compared with WT fractured mice (Fig. 3 a). In osteogenesis 
gene array, 24 genes (annexin A5 [Anxa5], OC [Bglap1], Bgn, 
immunopositivities for CD31, vWF, Flk-1 (Fig. 2 g), OC 
(Fig. 2 h), and adiponectin (Fig. 2 i) in SL cells. The alizarin 
red and oil red O staining also show characteristics of OBs 
and ADs, respectively (Fig. 2, h and i).
Figure 2.  Immunohistochemical detec-
tion of Tie2/-gal+ BM-derived stem/
progenitor cells in sites of fracture and 
multilineage differentiation capacity of SL 
BM cells. (a) Double-immunofluorescent 
staining for -gal (red) and CD31 (green) and 
-gal (red) and OC (OC, green) were per-
formed in peri-fracture sites 7 d after surgery 
in Lnk KO mice (left) and WT mice (right). 
Arrows indicate -gal/CD31 and -gal/OC 
double-positive capillaries and OBs, respec-
tively. Alcian blue/orange G–stained sections 
were also shown in parallel with immuno-
stained sections. (a, top) Dotted line indicates 
bone surface. Bars, 50 µm. Quantification of 
-gal+ ECs (b) and OBs (c). -gal and CD31 or 
OC double-positive cells were counted in 
three randomly selected high-power fields 
and averaged. *, P < 0.05 versus WT. EC  
(d; CD31 and vWF), OB (e; OC and collagen 1-
A1), and AD (f; LPL and PPAR) marker gene 
expressions were assessed by real-time RT-
PCR in SL cells cultured for 7 d with each cell 
lineage differentiation medium (*, P < 0.05;  
**, P < 0.001) and fluorescent immunostaining 
analyses with CD31 and vWF for ECs (g), OC 
for OBs for OBs (h), and LPL and PPAR for 
ADs (i) were also performed in SL cells after 
14 d in culture. The differentiated SL cells 
were also stained with alizarin red (h) and oil 
red O (i) for detecting OB and AD, respectively. 
Bars, 50 µm. Arrows indicate staining of posi-
tive cells. All data averaged with SEM from 
three independent experiments. All experi-
ments were obtained from triplicated assays.JEM VOL. 207, September 27, 2010 
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expression of several key genes as a quantitative analysis. The 
results demonstrated a significantly higher expression of EC 
markers (CD31, VE-cadherin [VE-cad], and KDR/Flk1) in 
Lnk KO group compared with WT group (CD31: Lnk KO, 
5.803 ± 0.667, WT, 1.171 ± 0.029, P < 0.01; VE-cad: Lnk 
KO, 7.693 ± 0.602, WT, 1.244 ± 0.006, P < 0.01; KDR: 
Lnk KO, 11.082 ± 1.036, WT, 1.415 ± 0.035, respectively, 
P < 0.01; n = 3; Fig. 3 c). The expression of bone-related 
Alk-6 [Bmpr1a], BMPR2, Col11a1, Col1a1, Col1A2, Col4a6, 
Col6a2, Ctsk, Dcn, FLG [Fgfr1], Smad2 [Madh1], Smad3 [Madh3], 
Collagenase-3 [Mmp13], MMP8, Gelatinase B [Mmp9], Osf2/Cbfa1 
[Runx2], SPARC, TGFb3, ALK-5 [Tgfbr1], VCAM-1, and Vdr) 
of Lnk-deficient fractured mice increased by >1.5-fold compared 
with WT fractured mice (n = 3; Fig. 3 b).
Real time RT-PCR analysis of the tissue that was RNA 
isolated from the peri-fracture site was also performed in the 
Figure 3.  Angiogenesis- and osteogenesis-related gene expressions in sites of fracture. (a and b) A series of gene expressions detected by DNA 
microarray analysis in granulation tissue samples of peri-fracture sites 7 d after surgery in Lnk KO and WT mice. Red circles indicate >1.5-fold and blue 
circles do over 2-fold-increased blots in Lnk KO mice compared with WT mice. The selected EC-related (c) and OB-related (d) gene up-regulation in the 
same samples as those in DNA microarray analysis were further confirmed by quantitative real-time RT-PCR analysis. VE-cad, Flk-1 (VEGF receptor 2); 
Col1A1, Col1A1; and Cbfa1, Cbfa1. **, P < 0.01 versus WT. All data averaged with SEM from three independent experiments. All experiments were obtained 
from triplicated assays.2212 Lnk-dependent axis of SCF–cKit signal for osteogenesis | Matsumoto et al.
enhanced  neovascularization  around 
the endochondral ossification area in 
Lnk KO mice compared with that in 
WT mice (Fig. 4 a). Neovasculariza-
tion assessed by capillary density was 
significantly enhanced in Lnk KO mice 
compared with that in WT mice (Lnk 
KO, 1,101.8 ± 97.7 vs. WT, 628.7 ± 
28.5/mm2; P < 0.01; n = 3; Fig. 4 b).
OB staining with OC (marker for 
mouse OB) 7 d after fracture also re-
vealed the augmentation of osteogenesis   
in newly formed bone area in Lnk KO 
mice compared with WT mice (Fig. 4 c).   
Osteogenesis assessed by OB density 
was significantly enhanced in Lnk KO 
mice  compared  with  WT  mice  (Lnk 
KO, 111.7 ± 13.2, WT, 66.7 ± 6.5/
mm2; P < 0.05; n = 3; Fig. 4 d). Callus 
formation was monitored radiographically to evaluate fracture 
healing process, and the relative callus areas detected by radiog-
raphy were quantified at week 1 in Lnk KO and WT group 
(Fig. 4 e). The relative callus area was significant larger in the   
Lnk KO group compared with the WT group (Lnk KO, 22.3 ±   
2.0, WT, 10.0 ± 3.0; P < 0.05; n = 3; Fig. 4 f). These results   
indicate the morphological enhancement of angiogenesis   
and osteogenesis in Lnk KO mice compared with WT mice 
in fracture-induced environment.
Physiological, radiological, and histological evidences  
of promoted fracture healing in Lnk KO mice
Blood perfusion and morphological fracture healing in each 
group was evaluated by laser Doppler perfusion imaging (LDPI) 
markers (OC, collagen1A1 [Col1A1], and Core binding factor 1 
[Cbfa1]) were significantly enhanced in Lnk KO group com-
pared with WT group (OC: Lnk KO, 29.707 ± 3.116, WT,   
1.294 ± 0.056, P < 0.01; Col1A1: Lnk KO, 46.189 ± 0.870, 
WT, 1.225 ± 0.225, P < 0.01; Cbfa1: Lnk KO, 13.586 ± 
1.767; WT, 0.999 ± 0.049, P < 0.01; n = 3; Fig. 3 d). These 
results indicate the enhancement of osteogenesis, as well as 
angiogenesis, at fracture sites in Lnk KO mice.
Morphological evidence of enhanced angiogenesis  
and osteogenesis in fractured Lnk KO mice
Enhanced angiogenesis and osteogenesis were further con-
firmed by immunohistochemistry. Vascular staining with 
CD31 (marker for mouse EC) 7 d after fracture demonstrated 
Figure 4.  Histological and radiographical 
evidences of enhanced angiogenesis/vas-
culogenesis and osteogenesis in Lnk KO 
fractured mice. Immunofluorescent staining 
for CD31 (green; a) and OC (OC, green; c)  
were performed in granulation tissue samples 
of peri-fracture sites in Lnk KO (left) and WT 
(right) mice 7 d after fracture. Alcian blue/
orange G–stained sections were also shown  
in parallel with immunostained sections.  
(bottom) Dotted line indicates bone surface. 
Bar, 50 µm. Quantification of capillaries  
(b) and OBs (d). CD31 positive capillaries and 
OC positive OBs were counted in 3 randomly 
selected high power fields and averaged. 
**, P < 0.01 versus WT. (e) Radiographical  
assessment of callus area in sites of fracture 7 d 
after surgery. Callus area is indicated in dotted 
line. (f) Relative callus areas are quantified and 
averaged. *, P < 0.05 versus WT. All data aver-
aged with SEM from three independent experi-
ments. All experiments were obtained from 
triplicated assays.JEM VOL. 207, September 27, 2010 
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fractured  limb  increased  until  2  wk 
post-fracture, and then decreased slowly 
in KO mice. In WT mice, the blood 
flow showed a mild increase until 1 wk 
post-fracture, and then decreased. In 
both groups, the ratio of fractured/ 
intact (contralateral) blood flow signifi-
cantly increased by week 1 (Fig. 5 b). 
There was no significant difference in the ratio 1 h after frac-
ture creation between the groups, whereas the ratio at weeks 
1, 2, and 3 were significantly higher in Lnk KO mice com-
pared with WT mice (0 wk: Lnk KO, 0.753 ± 0.067, WT, 
system  and  radiological  examinations  at  subsequent  time 
points after fracture. LDPI analysis (Fig. 5 a) demonstrated a 
severe loss of blood flow at the fracture sites 1 h after fracture 
creation in both groups. However, the blood flow of the 
Figure 5.  Increased blood perfusion and 
radiographically accelerated fracture 
healing in Lnk KO mice. (a) Tissue blood 
perfusion evaluated by LDPI system after 
surgery in the indicated time course. The frac-
tured sites are indicated in red square and 
intact contra-lateral sites are indicated in 
black square. (b) The mean flux-ratio was 
calculated by dividing mean flux value in red 
square with that in blue square and expressed 
as a relative mean flux value. **, P < 0.01 ver-
sus Week 0 and *, P < 0.05 versus WT. Data 
averaged with SEM from four independent 
experiments. Radiographical (c and e) and 
histological (f) assessment during fracture 
healing process in Lnk KO (left) and WT (right) 
mice. (c) Callus area is indicated in dotted line 
and the number of healed bones out of 20 is 
indicated in upper right corner of the image. 
Arrows indicate fracture sites. (d) The number 
of relative callus density is quantified. * and 
ns, P < 0.05 versus WT, n = 20 each. (e) The 
bone structure after healing was further as-
sessed by micro CT 28 d after surgery. (f) Bone 
density and number of trabecular bones were 
quantified in the micro CT images and aver-
aged. *, P < 0.05 versus WT. Data averaged 
with SEM from four independent experiments. 
(g) Biomechanical function test for healed 
bone in Lnk KO and WT mice 28 d after frac-
ture. Each parameter, ultimate stress (left), 
fracture energy (center) and extrinsic stiffness 
ratio (right), was evaluated as healed bone 
function. *, P < 0.05 versus WT. Data averaged 
with SEM from four independent experiments. 
(h) Toluidine blue staining was performed 
with granulation tissue at fracture site in the 
indicated time course. Chondrocytes are 
stained in blue and bone including newly 
formed trabecular bone is appeared in gray. 
Bar = 200 µm. (i) The degree of fracture  
healing in the toluidine blue stained sections 
was assessed by Allen’s classification in Lnk 
KO and WT mice. ** and ns, P < 0.01 versus 
WT. Data averaged with SEM from six inde-
pendent experiments.2214 Lnk-dependent axis of SCF–cKit signal for osteogenesis | Matsumoto et al.
Critical role of SCF–cKit signaling in enhanced SL cell 
mobilization from BM and recruitment to sites of fracture
Although  the  aforementioned  results  clearly  demonstrated 
enhanced  vasculogenesis/angiogenesis  and  osteogenesis  via 
SL or Tie2+ cell mobilization into PB and recruitment to sites 
of fracture in Lnk KO mice, the precise mechanism remains 
unclear. To explore the possible mechanism, we focused on 
the role of the stem/progenitor cell chemokine SCF, which 
is a ligand for the receptor cKit, in Lnk KO mice as well as in 
WT mice. Accordingly, mouse (m) SCF plasma levels were 
measured before and after fracture at subsequent time points 
in both types of mice. The plasma SCF levels were decreased 
after fracture surgery regardless of Lnk gene deficiency in mice; 
however, the extent of decrease was significantly limited during 
the fracture healing process and returned to over the baseline 
level at day 14 in Lnk KO mice compared with that in WT 
mice (prefracture: Lnk KO, 263.4 ± 9.4 vs. WT, 251.0 ± 
35.6 pg/ml; ns and 1 d post-fracture: Lnk KO, 194.1 ± 11.7 
vs. WT, 166.8 ± 12.7 pg/ml; 4 d post-fracture: Lnk KO, 
197.7 ± 7.2 vs. WT, 181.5 ± 28.9 pg/ml; 7 d post-fracture: 
Lnk KO, 214.7 ± 20.6 vs. WT, 190.7 ± 24.0 pg/ml; and 14 d 
post-fracture: Lnk KO, 284.2 ± 19.7 vs. WT, 207.3 ± 16.6 
pg/ml; P < 0.01 for each comparison; n = 5; Fig. 6 a).
Next, the gain and loss of function test of SCF for SL cell 
mobilization in PB was performed by FACS analysis. We in-
traperitoneally injected 20 µg/kg mSCF, soluble SCF recep-
tor (sKit, antagonist of SCF; Turner et al., 1995; Nakamura 
et al., 2004), or PBS into unfractured Lnk KO or WT mice 
for 5 d and examined SL cell kinetics in PB. The number of 
SL cells significantly increased, peaking at day 7 after SCF stimu-
lation in Lnk KO mice, but not in WT mice, and no SL cell 
number increase was observed in the other treatment groups 
(sKit treatment in Lnk KO mice and PBS treatment in Lnk 
KO mice and in WT mice; prestimulation: Lnk KO-PBS, 
13.0 ± 1.3; Lnk KO-SCF, 13.1 ± 0.7; Lnk KO-sKit, 15.3 ± 
0.2; WT-PBS, 8.1 ± 0.9; WT-SCF, 8.7 ± 0.6 × 104 cells/ml, 
ns, n = 5; 7 d post-stimulation: Lnk KO-SCF, 73.4 ± 4.1 vs. 
Lnk KO-PBS, 15.3 ± 2.5; Lnk KO-sKit, 10.0 ± 0.8; WT-PBS, 
8.3 ± 0.3; and WT-SCF, 12.8 ± 2.4 × 104 cells/ml, P < 
0.05, n = 5; and 14 d post-fracture: Lnk KO-SCF, 39.2 ± 6.2 
vs. Lnk KO-PBS, 13.6 ± 9.7; Lnk KO-sKit, 12.0 ± 0.3; WT-
PBS, 7.9 ± 0.9; and WT-SCF, 10.0 ± 0.9 × 104 cells/ml, P < 
0.01, n = 5; Fig. 6 b). Next, to identify the synergistic effect of 
fracture stress and SCF stimulation on SL cell mobilization, 
SCF with or without sKit and PBS was injected into fractured 
WT mice, and sKit alone was injected into fractured Lnk KO 
mice in the same way. In the fractured WT mice, the number 
of SL cells was significantly increased, peaking at day 7 post-
stimulation by SCF, but not by PBS, whereas no response of SL 
cell number was observed in nonfractured WT mice by SCF, 
and the effect of SCF on SL cell mobilization was completely 
cancelled by coinjection of sKit. The inhibitory effect of sKit 
on SL cell mobilization in PB was also observed partially in 
Lnk KO mice with fracture (prestimulation: Lnk KO-sKit-Fx, 
16.7 ± 2.1 vs. WT-PBS-Fx, 9.0 ± 2.1; WT-SCF-Fx, 8.3 ± 
0.7; and WT-SCF-sKit-Fx, 9.8 ± 0.7 × 104 cells/ml, P < 0.05, 
0.707 ± 0.045; 1 wk: Lnk KO, 1.370 ± 0.081, WT, 1.144 ± 
0.088; 2 wk: Lnk KO, 1.425 ± 0.103, WT, 1.110 ± 0.077;   
3 wk: Lnk KO, 1.241 ± 0.064, WT, 0.972 ± 0.030; P < 0.01 
for week 0 vs. weeks 1–3 in both Lnk KO and WT; P < 0.05 
for Lnk KO vs. WT in week 1–3; n = 4 mice/group/time-
point; Fig. 5 b).
In 70% (14 out of 20) of Lnk KO mice at week 2 and 
100% (20 out of 20) at week 3, the fracture healed with 
bridging callus formation radiographically, whereas in WT 
mice only 35% (7 out of 20) had healed at week 2 and 90% 
(18 out of 20) at week 3 (P < 0.05 in week 2; Fig. 5 c), which 
is consistent with the data in previous studies demonstrating 
the natural course in this animal model (Manigrasso and 
O’Connor,  2004).  To  evaluate  bone  remodeling,  bone 
absorption was monitored radiographically and relative callus 
density was quantified at week 3 and 4 in Lnk KO and WT 
group. Relative callus density was significantly lower in Lnk 
KO group compared with that in WT group (3 wk: Lnk KO, 
58.1 ± 2.4 vs. WT, 62.2 ± 6.8, ns; 4 wk: Lnk KO, 22.5 ± 2.8 
vs. WT, 40.2 ± 5.3, P < 0.05, n = 20; Fig. 5 d).
Morphological  and  functional  fracture  healing  in  each 
group was further evaluated by micro-computed tomography 
(micro-CT), histological analysis, and biomechanical exami-
nation 28 d after fracture surgery. The micro-CT results 
showed striking trabecular bone formation in Lnk KO mice 
compared to that in WT mice (Fig. 5 e). Quantitative analysis 
for bone formation was performed with micro-CT images 
and expressed as bone density (Fig. 5 f, left) and trabecula 
number (Fig. 5 f, right). Both parameters were significantly 
high in Lnk KO mice compared with that in WT mice (bone 
density: Lnk KO, 10.4 ± 1.5 vs. WT, 5.0 ± 0.3, P < 0.05, 
n = 4; number of trabecular: Lnk KO, 2.7 ± 0.3 vs. WT,   
1.3 ± 0.03, P < 0.01, n = 4; Fig. 5 f). Biomechanical examina-
tions by three-point bending test also showed significantly 
increased ultimate stress ratio (Lnk KO, 1.2 ± 0.02 vs. WT, 
0.8 ± 0.03, P < 0.001, n = 4), failure energy ratio (Lnk KO, 
2.2 ± 0.1 vs. WT, 1.2 ± 0.1, P < 0.001, n = 4), and extrinsic 
stiffness ratio (Lnk KO, 1.1 ± 0.1 vs. 0.4 ± 0.04, P < 0.01,   
n = 4; Fig. 5 g).
Histological  evaluation  with  toluidine  blue  staining 
demonstrated the enhanced endochondral ossification con-
sisting of numerous chondrocytes and newly formed trabec-
ular bone at week 1, bridging callus formation at week 2, 
and complete union at week 3 in Lnk KO mice. In contrast, 
although a callus formation was observed at week 1, bridg-
ing callus formation was rarely found at week 2 in WT mice 
(Fig. 5 h). The degree of fracture healing assessed by Allen’s 
classification (Allen et al., 1980) was significantly higher in 
the Lnk KO group compared with the WT group at week 1 
and 2 (1 wk: Lnk KO, 1.67 ± 0.21 vs. WT, 0.50 ± 0.22;   
2 wk: Lnk KO, 2.67 ± 0.21 vs. WT, 1.50 ± 0.22, P < 0.01, 
n = 6; 3 wk: Lnk KO, 3.67 ± 0.21 vs. WT, 3.17 ± 0.17, ns, 
n = 6; Fig. 5 i). These results indicate that Lnk KO mice 
have a potential for prompt fracture healing evaluated by 
not  only  radiographical  analysis  but  also  biomechanical 
functional examination.JEM VOL. 207, September 27, 2010 
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for 5 d, and angiogenesis/osteogenesis was evaluated by 
immunofluorescent staining for CD31 and OC 7 d after surgery 
(Fig. 6 d). As we expected, SCF stimulation significantly in-
creased both CD31+ capillary density (WT-SCF+/sKit, 830.4 ± 
55.7 vs. WT-SCF/sKit, 578.6 ± 55.2/mm2, P < 0.05, n = 5; 
Fig. 6 e) and OC+ OB density (WT-SCF+/sKit, 495.8 ±   
52.2 vs. WT-SCF/sKit, 350.0 ± 25.8/mm2, P < 0.05,   
n  =  5; Fig. 6 f) around the endochondral ossification area   
compared with PBS injection (control: SCF/sKit) in WT 
mice, and the effect of SCF on the increase of capillary 
density (WT-SCF+/sKit+, 601.8 ± 60.0 vs. WT-SCF+/sKit,   
n = 5; 7 d post-stimulation: WT-SCF-Fx, 34.1 ± 1.4 vs. 
WT-PBS-Fx, 12.9 ± 3.3 and WT-SCF-sKit-Fx, 8.0 ± 1.0 × 104 
cells/ml, P < 0.01, n = 5, [Lnk KO-sKit-Fx, 22.1 ± 3.4 × 104]; 
14 d post-fracture: WT-SCF-Fx, 17.9 ± 2.0 vs. WT-PBS-Fx,   
8.5 ± 1.9 and WT-SCF-sKit-Fx, 7.7 ± 1.3 × 104 cells/ml,   
P < 0.05, n = 5, [Lnk KO-sKit-Fx, 15.0 ± 4.8 × 104]; Fig.6 c).
We further confirmed that SCF-induced stem/progenitor 
cell mobilization mediated enhanced angiogenesis and osteo-
genesis in sites of fracture by SCF–cKit signaling inhibition 
study in vivo. The mSCF (20 µg/kg/day), sKit (20 µg/kg/day), 
or PBS was injected intraperitoneally into mice with fracture 
Figure 6.  Enhanced SL cell mobilization by SCF stimulation in Lnk KO mice. (a) Serum mouse SCF levels were measured in Lnk KO and WT mice 
after fracture by ELISA. ††, P < 0.01; *, P < 0.05 versus Pre, respectively. (b) The number of circulating SL cells in Lnk KO and WT mice with injection of PBS 
(control; Lnk KO-PBS and WT-PBS), SCF (SCF, 20 µg/kg; Lnk KO-SCF and WT-SCF), or soluble SCF receptor (=c-kit ligand, sKit, 20 µg/kg; Lnk-sKit) were 
assessed by FACS in the indicated time course after the treatment. †† and †, P < 0.01 and P < 0.05 versus Pre, respectively. ** and *, P < 0.01 and P < 0.05 
versus WT-PBS, WT-SCF, Lnk KO-PBS, and Lnk KO-sKit, respectively. (c) The number of circulating SL cells in WT mice with fracture and injection of PBS, 
SCF (20 µg/kg), or SCF (20 µg/kg)+ sKit (WT-fx-PBS, WT-fx-SCF, or WT-fx-SCF-sKit, respectively), WT mice without fracture and SCF (20 µg/kg; WT-SCF), 
and Lnk KO mice with fracture and sKit (Lnk KO-fx-sKit) were assessed by FACS in the indicated time course after the treatment. †† and †, P < 0.01 and  
P < 0.05 versus Pre, respectively. * and **, P < 0.05 and P < 0.01 versus WT-fx-SCF-sKit, respectively. (d) Immunofluorescent staining for CD31 (green) and 
OC (OC, green) were performed in granulation tissue samples of peri-fracture sites in Lnk KO (left one panel) and WT (right two panels) mice 7 d after 
fracture. Alcian blue/orange G stained sections were also shown in parallel with immunostained sections (lower panels to each immunofluorescent stain-
ing images). Mouse phenotype with SCF (20 µg/kg) or sKit (20 µg/kg) administration (+) is indicated in the lower part of images. Dotted line indicates 
bone surface. Bar = 50 µm. Quantification of capillaries (e) and OBs (f). CD31 positive capillaries and OC positive OBs were counted in 3 randomly selected 
high power fields and averaged.**, P < 0.01 and *, P < 0.05. All data averaged with SEM from five independent experiments. All experiments were obtained 
from triplicated assays.2216 Lnk-dependent axis of SCF–cKit signal for osteogenesis | Matsumoto et al.
examined in Lnk KO OBs and WT OBs with SCF stimula-
tion in the presence or absence of sKit. The significantly high 
BMP-2 mRNA expression was observed in Lnk KO OBs 
and SCF-treated WT OBs compared with WT OBs (Lnk 
KO-SCF/sKit, 2.732 ± 0.551 and WT-SCF+/skit, 2.576 ± 
0.369 vs. WT-SCF/skit, 1.189 ± 0.161, P < 0.01, n = 3 
in each group) and the BMP-2 mRNA up-regulation in Lnk 
KO OBs and that in SCF-treated WT OBs were significantly 
inhibited by sKit (Lnk KO-SCF/sKit+, 1.391 ± 0.203 vs. 
Lnk KO-SCF/sKit, 2.732 ± 0.551 and WT-SCF/sKit+, 
0.911 ± 0.136 vs. WT-SCF+/skit, 2.576 ± 0.369, P < 0.01, 
n = 3; Fig. 7 e). These results indicate that BMP-2 might be 
involved in the SCF–cKit signaling pathway, which is critical 
for OB terminal differentiation and mineralized matrix forma-
tion leading to osteogenesis enhancement in Lnk KO mice.
Lnk gene deficiency in BM cells plays a critical role  
for fracture healing
Finally, we examined whether Lnk gene deficiency in BM 
stem/progenitor cells, but not in bone with surrounding tis-
sue. To test this hypothesis, we assessed fracture healing in a 
murine BMT model. BM cells isolated from either Lnk KO 
mice or WT mice were transplanted to Lnk KO mice after 
lethal irradiation, and generated the following chimera mice: 
1) Lnk KO mice with Lnk KO BM and 2) Lnk KO mice 
with WT BM. These chimera mice underwent surgery for 
fracture and evaluated the fracture healing by micro-CT im-
aging system and biomechanical analysis 28 d after surgery. 
The results of micro-CT exhibited striking trabecular bone 
formation in Lnk KO mice with Lnk KO BM than that in 
Lnk KO mice with WT BM (Fig. 8 a). Quantitative analysis 
for bone formation was performed with micro-CT images, 
and expressed as bone density (Fig. 8 b, left) and trabecula 
number (Fig. 8 b, right). The both parameters were signifi-
cantly great in Lnk KO mice with Lnk KO BM compared 
with that in Lnk KO mice with WT BM (Bone density: Lnk 
KO mice with Lnk KO BM, 11.3 ± 0.4 vs. Lnk KO mice 
with WT BM, 8.9 ± 0.8, P < 0.05, n = 4 and Number of 
trabecular: Lnk KO mice with Lnk KO BM, 3.0 ± 0.2 vs. 
Lnk KO mice with WT BM, 1.8 ± 0.1, P < 0.05, n = 4). 
Biomechanical examinations by three-point bending test also 
showed significantly increased ultimate stress ratio (Lnk KO 
mice with Lnk KO BM, 1.1 ± 0.05 vs. Lnk KO mice with 
WT BM, 0.5 ± 0.08, P < 0.05, n = 4), failure energy ratio 
(Lnk KO mice with Lnk KO BM, 3.9 ± 0.07 vs. Lnk KO 
mice with WT BM, 1.5 ± 0.05, p<,0.001 n = 4), and extrinsic 
stiffness ratio (Lnk KO mice with Lnk KO BM, 0.8 ± 0.03 
vs. Lnk KO mice with WT BM, 0.2 ± 0.03, P < 0.05, n = 4; 
Fig. 8 c). These results suggest that Lnk gene deficiency in 
BM cells, rather than in bone with surrounding tissue, is crit-
ical for enhanced fracture healing.
DISCUSSION
In this paper, we have demonstrated that both vasculogenesis 
and osteogenesis were enhanced via large-scale HSC/EPC mo-
bilization in circulation and recruitment to sites of fracture, 
830.4 ± 55.7/mm2, P < 0.05, n = 5; Fig. 6 e) and OB den-
sity (WT-SCF+/sKit+, 344.6 ± 20.7 vs. WT-SCF+/sKit, 
495.8 ± 52.2/mm2, P < 0.05, n = 5; Fig. 6 f) was significantly 
reversed by coadministration of sKit with SCF. The sKit ad-
ministration also significantly reduced both capillary density 
(Lnk KO-SCF/sKit+, 653.6 ± 20.4 vs. Lnk KO-SCF/sKit, 
1,101.8 ± 97.7/mm2, P < 0.01, n = 5; Fig. 6 e) and OB density 
(Lnk KO-SCF/sKit+, 389.3 ± 17.3 vs. Lnk KO-SCF/sKit, 
558.9 ± 37.9/mm2, P < 0.01, n = 5; Fig. 6 f) in Lnk KO mice 
to levels similar to those found in WT mice with or without 
coadministration of SCF and sKit. These findings indicate that 
enhanced SL cell mobilization into PB and its recruitment to 
fracture sites in Lnk KO mice is, at least in part, regulated by 
SCF–cKit signaling pathway.
SCF–cKit signaling-dependent terminal differentiation  
of Lnk-deficient OBs for osteogenesis
Although there is no doubt about stimulated stem/progeni-
tor cell recruitment to sites of fracture by SCF–cKit signaling 
activation in WT and Lnk KO mice, the Lnk-regulated differ-
ential potential of progenitors needed to be evaluated, especially 
regarding osteogenesis. We isolated mouse calvarial OBs from 
3–5-d-old Lnk KO mice and WT mice, and compared the dif-
ferentiation capacity in osteogenic condition medium after 7, 
14, and 21 d in culture. Alkaline phosphatase (ALP) staining ex-
hibited larger nodule formation in Lnk KO OBs than in WT 
OBs until day 14 (Fig. 7 a). In addition, OB mineralized matrix 
formation assessed by alizarin red staining in Lnk KO OBs was 
striking compared to that in WT OBs (Fig. 7 a). Quantitative 
analysis for calcium content in culture medium was also signifi-
cantly high in Lnk KO OBs than that in WT OBs after 21 d in 
culture, (Lnk KO-SCF/sKit, 15.9 ± 3.5 vs. WT-SCF/
sKit, 0.6± 0.1 mg/ml, P < 0.01, n = 5; Fig. 7 d). However, the 
number of OB CFUs (CFU-O) showed no statistical differences 
between the two groups at each time point (unpublished data).
Next, we investigated whether this enhancement of dif-
ferentiation and mineralized matrix formation in Lnk KO 
OBs was also regulated by SCF signals. First, we confirmed 
the significantly higher mRNA expression of SCF in Lnk 
KO mice than that in WT OBs by real-time RT-PCR analysis 
(Lnk KO, 1.707 ± 0.345 vs. WT, 0.587 ± 0.111, P < 0.05, 
n = 3; Fig. 7 b). In WT mice, as we expected, SCF morpho-
logically enhanced mineralized matrix formation after 21 d in 
culture (WT-SCF+/sKit), and the effect of SCF on WT 
OBs (WT-SCF+/sKit+) and Lnk KO OBs (Lnk KO-SCF/
sKit+) was inhibited by sKit (Fig. 7 c). Calcium content in 
WT OBs with SCF was significantly higher than that in WT 
OBs without SCF (WT-SCF+/sKit, 7.1 ± 1.4 vs. WT-SCF/
sKit, 0.6± 0.1 mg/ml, P < 0.05, n = 5), and the effect was 
reversed by coincubation of SCF and sKit in WT OBs (WT-
SCF+/sKit, 1.0 ± 0.3 vs. WT-SCF+/sKit, 7.1 ± 1.4 mg/ml, 
P < 0.05, n = 5) and in Lnk KO OBs (Lnk KO-SCF/sKit+, 
4.8  ±  1.1  vs.  Lnk  KO-SCF/sKit,  15.9  ±  3.5  mg/ml,   
P < 0.01, n = 5; Fig. 7 d). We then further investigated the role 
of SCF–cKit signaling, focusing on an osteogenesis-related 
key molecule, bone morphogenetic protein (BMP)-2, was   JEM VOL. 207, September 27, 2010 
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nonadherent population of BM cells contains primitive cells able 
to generate both hematopoietic and osteocytic lineage cells 
(Olmsted-Davis et al., 2003). Zhang et al. (2003) reported 
that depleting a receptor of BMP in OBs caused a doubling in 
both OB and HSC populations in BM niche. Calvi et al. 
(2003) also found a parallel expansion of the HSCs when the 
number of OBs was increased by parathyroid hormone infusion. 
These findings indicate that osteogenesis and hematopoiesis/
vasculogenesis  closely  regulated  each  other  in  terms  of   
simultaneously resulting in accelerated bone healing in a Lnk-
deficient mouse fracture model.
BM SL cells, recognized as an HSC/EPC-enriched frac-
tion (Takahashi et al., 1999), were reported to synthesize ALP, 
collagen, and OC and form a mineralized matrix in culture 
over a decade ago (Van Vlasselaer et al., 1994). It has also 
been reported that BM side population cells, which contain 
hematopoietic repopulating cells, can also engraft in bone   
after transplantation (Dominici et al., 2004), and that the 
Figure 7.  Enhanced mineralization of OBs in Lnk-deficient mice. (a) OBs (OBs) isolated from Lnk KO and WT mice were cultured in osteogenic con-
dition medium. Cells were assessed morphologically by ALP staining (blue) at day 14 and by alizarin red staining (red) at day 21. Upper panels show mac-
roscopic images of whole culture dishes and lower panels show magnified images of nodule with mineralized matrix formation. (b) Real-time RT-PCR of 
cultured OBs for SCF mRNA expression at day 7 in Lnk KO and WT mice. Mouse heart and bone are used as positive controls for mouse endothelial and 
bone-related gene detection (not depicted) *, P < 0.05. Data averaged with SEM from three independent experiments. Experiments were obtained from 
triplicated assays. (c) The mineralized matrix formation was assessed by alizarin red staining 21 d after osteogenic culture in Lnk KO OBs with sKit (10 µg/ml) 
and in WT OBs in the presence of SCF (100ng/ml) with or without sKit (10 µg/ml). Upper panels show macroscopic images of whole culture dishes and 
lower panels show magnified images of nodule with mineralized matrix formation. Calcium content was measured by ELISA (n = 5 each; d) in culture 
medium and BMP2 mRNA expression (e) was analyzed by real-time RT-PCR (n = 3 each) in Lnk KO OBs with sKit (10 µg/ml) and WT OBs in the presence of 
SCF (100ng/ml) with or without sKit (10 µg/ml). *, P < 0.05 and **, P < 0.01. Experiments were obtained from triplicated assays.2218 Lnk-dependent axis of SCF–cKit signal for osteogenesis | Matsumoto et al.
would  also  be  critical  for  fracture  healing 
(Matsumoto et al., 2006). Indeed, cDNA 
microarray and quantitative real-time RT-
PCR analyses also exhibited up-regulation of 
pro-angiogenic/-osteogenic gene expressions, 
which is consistent with increased blood per-
fusion and callus formation, in sites of frac-
ture  with  recruited  EPCs  in  Lnk-deficient 
mice. The series of findings suggest that both 
direct  and  indirect  contribution  of  BM-
derived EPCs to prompt and functional frac-
ture healing with sufficient mineralization in 
Lnk-deficient mice.
Takaki et al. (2000, 2002) reported that 
Lnk acts as a negative regulator in the SCF–
cKit signaling pathway. Although the role of 
Lnk system has gradually been clarified in 
the field of hematology, nothing is known 
about it’s role in skeletal biology and bone 
regeneration and repair. Here, we have pro-
vided  evidence  that  enhanced  HSC/EPC 
mobilization into PB and its recruitment to 
the fracture site in Lnk-deficient mice are 
regulated, at least in part, by SCF–cKit signaling pathway, which 
was proved by gain and loss of function test using SCF and 
sKit. However, enhanced vasculogenesis and osteogenesis in 
Lnk-deficient mice was shown to be significantly superior to 
that of SCF-treated WT mice, suggesting that another mech-
anism besides SCF–cKit signaling pathway is involved in the 
Lnk signal lacking accelerated bone healing. Indeed, molec-
ular cDNA array analysis showed that BMPR2 mRNA expres-
sion was up-regulated more in Lnk KO mice than in WT mice. 
Moreover, lack of Lnk or SCF supplement in OBs induced 
terminal differentiation and mineralized matrix formation 
with increased BMP2 gene expression, which was blocked 
by the SCF antagonist sKit. These findings are consistent with 
previous studies in which cKit expression is shown in OBs and 
P-2 enhances OB differentiation. (Bilbe et al., 1996; Hassel et al., 
2006) Collectively, it is suggested that OB differentiation and 
maturation is enhanced in Lnk-deficient mice via the mecha-
nism of BMP2-involved SCF–cKit signaling pathway.
microenvironmental interaction for regenerative activity in 
BM. We have also previously reported that mobilization of 
BM-derived HSCs/EPCs were triggered by fracture onset 
and recruited to sites of fracture (Matsumoto et al., 2008).   
In this study, we have provided evidence of enhanced trans-
lineage differentiation of Sca1+/Tie2+ cells into OBs and ECs 
both in vitro and in vivo, as well as that of mobilization of 
BM-KSL cells and PB-SL cells in circulation in Lnk-deficient 
mice, which is consistent with the previous report that BM 
cells of Lnk-deficient mice are competitively superior in he-
matopoietic population to those of WT mice (Takaki et al., 
2002). These data suggest that a large number of BM-derived 
EPCs might not only be mobilized from BM but also re-
cruited to fracture site, differentiating into ECs and OBs by 
lack of Lnk signaling. In addition to the direct contribution 
of recruited EPCs for fracture repair, indirect contribution of 
EPCs, i.e., the paracrine effect on bone tissue regeneration via 
promotion of osteogenesis/angiogenesis with resident cells, 
Figure 8.  Radiographical and biomechanical 
function assessment of fracture healing in Lnk 
KO BMT-Lnk KO mice and WT BMT- Lnk KO 
mice. (a) The bone structure after healing was as-
sessed by micro-CT 28 d after surgery. (b), Bone den-
sity and number of trabecular bones were quantified 
in the micro-CT images and averaged. *, P < 0.05 ver-
sus Lnk KO-BMT, n = 4 each. (c) Biomechanical func-
tion test for healed bone was also assessed 28 d after 
fracture. Each parameter, ultimate stress (left), frac-
ture energy (center) and extrinsic stiffness ratio (right), 
was evaluated as healed bone function. *, P < 0.05 
and **, P < 0.001 versus Lnk KO-BMT. All data aver-
aged with SEM from four independent experiments.JEM VOL. 207, September 27, 2010 
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Isolation of Lin BM cells. To confirm the kinetics of KSL or SL cells in 
BM and PB, we detected KSL or SL cells at pre-fracture and 1, 4, 7, and 14 d 
post-fracture by FACS analysis (n = 3 at each day).
BM cells were obtained by flushing femurs and tibiae or PB cells were 
aspirated from the hearts of 10-wk-old Lnk KO mice or WT mice with PBS 
containing 5% FCS. MNCs were obtained by gradient separation onto a Ficoll 
Histopaque gradient. Separation of Lin cells was performed by labeling 
MNCs with a lin separation kit (BD) containing biotin-conjugated Mac1, 
B220, CD3e, Ter119, Ly6G, and CD45R antibodies, followed by streptavidin-
conjugated magnetic beads and BD IMagnet separation before Lin MNCs 
were counted.
Multilineage differentiation culture of SL BM cells. Mouse SL cells 
were isolated from BM MNCs by Lin+ cell depletion with MACS system 
(Miltenyi Biotec) followed by FACS system with an anti–mouse Sca-1   
antibody  (FACSAria;  BD),  and  cultured  in  -modified  Eagle’s  medium   
(-MEM; Cambrex Bio Science). After 3 wk in culture, cells (105/well) 
were placed in a 6-well plate and further cultured only for osteogenic and 
adipogenic induction.
For endothelial induction, freshly isolated SL cells were cultured in 
EBM-2 medium supplemented with 10% FBS and EGM-2 Bullet kit (Lonza) 
in Pronectin F (Sanyo Chemical, Inc.)–coated culture plate for 7 d. For 
osteogenic and adipogenic induction, cells were cultured in -MEM sup-
plemented with 10% FBS. 2 mM L-glutamine, 60 µM ascorbic acid, 10 mM 
-glycerophosphate  and  0.1  µM  dexamethasone  (Sigma-Aldrich)  and   
-MEM supplemented with 1 µM dexamethasone, 60 µM indomethacin, 
and 5 µg/ml insulin (Sigma-Aldrich) for 3 wk, respectively. After the above in-
duction cultures, each lineage differentiation was confirmed by real-time 
RT-PCR and fluorescent immunocytostaining for the indicated specific 
markers. Also, calcium deposits were detected by Alizarin red staining and 
formations of lipid droplets were assessed by Oil Red O staining as charac-
teristics of OB and AD, respectively. Freshly isolated SL cells and those cul-
tured for 3 wk in -MEM alone were used as controls for endothelial 
induction and osteogenic/adipogenic induction in real-time RT-PCR 
analysis, respectively.
Flow cytometry studies and monoclonal antibodies. Regular flow 
cytometric profiles were analyzed with a FACSCalibur analyzer and CELL-
Quest software (BD). The instrument was aligned and calibrated daily using 
a four color mixture of CaliBRITE beads (BD) with FACSComp software 
(BD). Dead cells were excluded from the plots beads on propidium iodide 
(PI) staining (Sigma-Aldrich). Lineage-depleted MNCs were washed twice 
with HBSS containing 3.0% heat-activated FCS, and incubated with 10 µl 
of FcR Blocking Regent to increase the specificity of monoclonal antibodies 
(Miltenyi Biotec) for 20 min at 4°C, and incubated with the monoclonal anti-
bodies for 30 min at 4°C. The stained cells were washed three times with 
PBS containing 3.0% FCS, and resuspended in 0.5 ml of HBSS/3%FCS/PI, 
and analyzed by FACScan caliber flow cytometer (BD). The following mono-
clonal antibodies were used to characterize the lineage-depleted MNCs: APC-
conjugated anti-cKit (BD), FITC-conjugated anti-Sca1 (BD), IgG1-PE isotype 
controls (BD), IgG1-FITC isotype controls (BD), and PI (Sigma-Aldrich).
Induction of femoral fracture. All surgical procedures were performed 
under anesthesia and normal sterile conditions. Anesthesia was performed with 
ketamine hydrochloride (60 mg/kg) and xylazine hydrochloride (10 mg/kg) 
administered intraperitoneally. We followed Manigrasso’s model of closed 
femur fracture (Manigrasso and O’Connor, 2004). A lateral parapatellar knee 
incision on the right limb was made to expose the distal femoral condyle.   
A 2-mm wedge was made using a 27-gauge needle on the intercondyle of the 
femur and then a 0.5-mm-diam, stainless wire was inserted in a retrograde 
fashion. The wire was advanced until its proximal end was positioned stable 
to the greater trochanter and the distal end was cut close to the articular sur-
face of the knee. A transverse femoral shaft fracture was then created in the 
right femur of each mouse by three-point bending. The wound was then   
irrigated with 10 cc of sterile saline and skin was closed in layers with 5–0   
Another interesting finding in cDNA microarray data is 
that expression of vascular cell adhesion molecule (VCAM)-1, 
a differentiation-predicting marker for osteogenesis (Fukiage 
et al., 2008), is significantly up-regulated in sites of fracture 
and EC-related markers in Lnk KO mice compared with 
WT mice. Fitau et al. (2006) reported that high expression of 
VCAM-1 at both the mRNA and protein level in Lnk-
deficient mice was regulated in TNF-treated ECs by extra-
cellular signal-related kinase (Erk) 1/2 pathways. In addition, 
Rhee et al. (2006) reported that Erk 1/2 expression was pres-
ent within mesenchymal precursor cells during distraction 
osteogenesis and that Erk expression closely correlates with 
BMP 2/4 expression. Other studies also indicated that the acti-
vation of Erk 1/2 pathway in OBs related to mechanical strain 
and fluid flow (Jessop et al., 2002; Alford et al., 2003; Liu et al., 
2008). Based on this evidence and our findings, the Erk1/2- 
and BMP-2/4–involved VCAM-1 signaling pathway is consid-
ered to be another mechanism for accelerated fracture healing 
via vasculogenesis and osteogenesis in Lnk KO mice, and fur-
ther investigation will be required to clarify the entire mecha-
nism for bone regeneration in a Lnk-deficient system.
In conclusion, our data provide novel evidence that the 
Lnk system acts as a negative regulator in the SCF–c-Kit sig-
naling pathway and that Lnk deficiency modulates both vas-
culogenesis and osteogenesis via SL stem cell mobilization in 
PB and Tie2+ BM cell recruitment to sites of fracture, although 
Tie2+ cells are not necessarily defined as stem cells, but are 
likely EPCs. In addition, lack of Lnk signaling further en-
hances BMP2-induced OB matrix mineralization in vitro. 
These pathophysiological changes led to accelerated bone heal-
ing in Lnk-deficient mice. In the field of skeletal regenera-
tion, recently BM-derived mesenchymal stem cells or whole 
BMs have been used for injured bone (Petite et al., 2000) or 
osteogenesis imperfecta (Horwitz et al., 1999) in preclinical 
studies. However, there are several issues to be resolved for 
open reduction, such as invasiveness in cell transplantation 
procedure and possible complications caused by infection. 
The major strength of this study relies on the concept that 
negative control of Lnk system for bone regeneration leads to 
clinical feasibility by generating a Lnk-inhibitory compound. 
This is the first study demonstrating physiological functions 
of the adaptor protein Lnk in bone regeneration and suggests 
that inhibition of the Lnk system could be a novel therapeu-
tic application for genetic bone diseases and bone injuries.
MATERIALS AND METHODS
Mice. Lnk/ mice, whose generation and genomic cloning were described 
previously (Takaki et al., 2000) were backcrossed with C57BL/6 (B6-Ly5.2) 
>10 times and paired with age-matched WT mice as controls. Mice con-
genic for the Ly5 locus (B6-Ly5.1) were bred and maintained at the animal 
facility of Institute of Physical and Chemical Research Center for Develop-
mental Biology, Kobe, Japan. The mice were fed a standard maintenance 
diet and provided water ad libitum. Male 10–12-wk-old Lnk/ and WT 
mice were used in this study. The institutional animal care and use commit-
tees of the Institute of Physical and Chemical Research Center for Devel-
opmental  Biology  approved  all  animal  procedures,  including  human   
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isolation, we made single-strand cDNA using a reverse transcription kit (In-
vitrogen) and used it as template for real-time PCR with SYBR Green PCR 
Master Mix (Applied Biosystems) and gene-specific primers in an Oligo soft-
ware (Takara Bio Inc.). The mean cycle threshold values from quadruplicate 
measurements were used to calculate the gene expression, with normaliza-
tion to GAPDH as an internal control.
Primer size and sequences. mCD31 (224 bp): sense 5-TCCCCACC-
GAAAGCAGTAAT-3; antisense 5-CCCACGGAGAAGTACTCTGTC-
TATC-3, mVE-cad (369 bp): sense 5-GAGCTAAGAGGACCCTCTGC-
TACTC-3; antisense 5-TGGGCCTCTTTGTGTCTGTATG-3, mFlk-1 
(346 bp): sense 5-TGGCGTTTCCTACTCCTAATGA-3; antisense 
5-GAAGCCACAACAAAGCTAAAATACTGAG-3, mvWF (20 bp): sense 
5-ACGCCATCTCCAGATTCAAG-3; antisense 5-AAGCATCTCCC-
ACAGCATTC-3, mOC (187 bp): sense 5-CTGACCTCACAGATCC-
CAAGC-3; antisense 5-TGGTCTGATAGCTCGTCACAA-3, mCol1A1 
(107 bp): sense 5-CAATGGTGAGACGTGGAAAC-3; antisense 5-GGTT-
GGGACAGTCCAGTTCT-3,  mCbfa1  (151  bp):  sense  5-AACGAT-
CTGAGATTTGTGGGC-3; antisense 5-CCTGCGTGGGATTTCTT-
GGTT-3, mLPL (65 bp): sense 5-AGCTGGGAGCAGAAACTGTG-3; 
antisense  5-CATGTGGGTTGGTGTTCAGA-3,  mPPAR  (50  bp): 
sense 5-CTGGCCTCCCTGATGAATAA-3; antisense 5-AATCCTT-
GGCCCTCTGAGAT-3, mSCF (72 bp): sense 5-CCAAAAGCAAAGC-
CAATTACAAG-3;  antisense  5-AGACTCGGGCCTACAATGGA-3, 
mBMP-2 (73 bp): sense 5-TCACTTATAGCCGCATTATCTTCTTC-3; 
antisense 5-TTGGTTTATCCATGAGGCTAACTG-3, and mGAPDH 
(484  bp):  sense  5-GTGAGGCCGGTGCTGAGTATG-3;  antisense   
5-AGGCGGCACGTCAGATCC-3.
Tissue harvesting. Mice were euthanized with an overdose of ketamine and 
xylazine. Bilateral femurs were harvested and embedded in OCT compound, 
snap frozen in liquid nitrogen, and stored at 80°C for histochemical staining 
and immunohistochemistry. Rat femurs in OCT blocks were sectioned, and   
6-µm serial sections were collected on slides, followed by fixation with 4.0% 
paraformaldehyde at 4°C for 5 min, and then stained immediately.
Morphometric  evaluation  of  capillary  and  OB  density. Immuno-
histochemical staining with anti–mouse rat CD31 (Biogenesis) for mouse EC 
marker or anti–mouse goat OC (Santa Cruz Biotechnology, Inc.) for mouse 
OB was performed. The secondary antibodies for each immunostaining are 
as follows: FITC-conjugated anti–rat IgG (H+L; Jackson ImmunoResearch 
Laboratories) for CD31 and FITC-conjugated anti–goat IgG (H+L; Jackson 
ImmunoResearch Laboratories) for OC. Capillary or OB density was mor-
phometrically evaluated by histological examination of 5 randomly selected 
fields of tissue sections recovered from segments of soft tissue in the peri-
fracture site. Capillaries were recognized as tubular structures positive for 
CD31. OB-like cells were recognized as lining or floating cells positive for 
OC on new bone surface. All morphometric studies were performed by two 
examiners who were blinded to treatment.
LDPI assessment. LDPI (Moor Instrument; Wardell et al., 1993; Linden 
et al., 1995) was used to record serial blood flow measurements over the 3 wk 
post-fracture course. In these digital color-coded images, red hue indicated 
regions with maximum perfusion; medium perfusion values are shown in 
yellow; lowest perfusion values are represented as blue. This was done under 
anesthesia with the animal supine and both limbs fully fixed.
Fluorescent immunostaining. To detect Tie2+ cell-derived neovascular-
ization in Lnk KO mice with Tie2/LacZ Lnk KO BM at the fracture site, 
double immunohistochemistry was performed with anti–mouse rat CD31 
(1:50; BD) or anti–mouse goat OC (1:250; Biogenesis) and anti–rabbit -gal 
(1:1,000; Cortex) to detect Tie2+ cell-derived ECs or OBs. For characteriza-
tion of multilineage cell types in SL cells, the following primary antibodies 
were used: anti–mouse rat CD31 (1:50; BD), anti–mouse goat vWF (1:100; 
Santa Cruz Biotechnology, Inc.), anti–mouse rat Flk-1 (1:100; Chemicon), 
anti–mouse goat OC (1:250; Biogenesis), and anti–mouse mouse adiponectin 
nylon sutures. Postoperative pain was managed by administration of subcu-
taneous injection of buprenorphine hydrochloride after surgery. Unprotected 
weight bearing was allowed immediately after the operation. The left nonfrac-
tured femur served as a control.
20 animals were assigned to each group for radiological assessment, and 
every additional three to five animals in each group were assigned for each 
study. If the fracture produced was not a stable transverse fracture or if evi-
dence of deep infection developed then animals were excluded from the 
study and replaced with another animal. Thus, six mice with comminuted 
fractures were replaced during the experiment. No mice developed infec-
tions, as confirmed by radiograph.
Mouse  BMT  model. Male Lnk KO mice and WT mice (C57BL6/J; 
CLEA Japan, Inc.) aged 6 wk were used as recipients for BMT. Transgenic 
mice of B6/N-TgN (Tie-2-LacZ)182Sato (Jackson ImmunoResearch Laborato-
ries), which were generated by backcrossing FVB/N-TgN (Tie-2-LacZ)182Sato 
mice and C56BL6/J mice, were used as donors for the BMT. The procedure 
of BMT was performed as described previously, with some modifications   
(Ii et al., 2005). In brief, the recipient mice were lethally irradiated for BM 
ablation with 12.0 Gy and received 5 million donor BM MNCs. At 4–6 wk 
after BMT, by which time the BM of the recipient mice was reconstituted, 
surgery for fracture induction was performed. The granulation tissue of frac-
tured BMT mice were harvested 7 and 28 d after surgery for histological, 
radiographical, and biomechanical function analyses.
Gene expression analysis via cDNA microarray. Total RNA was ob-
tained from tissues at the peri-fracture site at day 7 using Tri-zol (Life Tech-
nologies)  according  to  the  manufacturer’s  instructions.  cDNAs  were 
synthesized using 1 µg total RNA in the presence of Superscript II and Oligo 
(dT)1218 (both from Invitrogen). PCR was performed in a 20-µl reaction so-
lution containing 2 µl 10 X PCR buffer, 150 nmol MgCl2, 10 nmol dNTP, 
20 pmol primer, 1 µl 10× diluted cDNA, and 1 U RedTag DNA polymerase 
(Sigma-Aldrich). PCRs were run as follows: 35 cycles of 94°C for 30 s, 55°C 
for 30 s and 72°C for 30 s, and a final extension for 10 min at 72°C. Primer 
sequences are shown in the Primer size and sequence section. Nonradioac-
tive GEArray Q series cDNA expression array filters (Mouse Angiogenesis 
Gene Array [MM-009] and Mouse Osteogenesis Gene Array [MM-026]; 
SuperArray Inc.) were used to perform focused array analysis as described by 
the manufacturer. Microarray databases are available at the National Center 
for Biotechnology Information Gene Expression Omnibus (GEO; http://
www.ncbi.nlm.nih.gov/geo/) under accession no. GPL1121 for MM-009 
and GPL1143 for MM-026. In brief, biotin dUTP-labeled cDNA probes 
were generated in the presence of a designed set of gene-specific primers   
using total RNA (2 µg per filter) and 200 U MMLV reverse transcription 
(Promega,  Madison,  WI,  USA).  The  array  filters  were  hybridized  with   
biotin-labeled probes at 60°C for 17 h. Filters were first washed twice with 
2× saline sodium citrate buffer (SSC)/1% sodium dodecyl sulfate (SDS) and 
then twice with 0.1× SSC/1% SDS at 60°C for 15 min each. Chemilumi-
nescent detection steps were performed by subsequent incubation of the   
filters with ALP-conjugated streptavidin and CDP-Star substrate. The images 
were captured using ChemoFlure 8900 (Alpha Innotech). For data analy-
sis, positive and negative spots were independently identified and verified by at 
least two people. Only matched positive and negative results from two inde-
pendent experiments were used for analysis. For quantification, intensity of 
spots was first measured by National Institutes of Health image software 
(ImageJ) and then the mean intensities derived from the blank spots were 
subtracted. These subtracted intensities were divided by the mean intensities 
from GAPDH (three spots in each array), to obtain a relative intensity for 
each spot. These relative intensities were used to compare gene express levels 
between the control and the stimulated groups.
Real-time  quantitative  RT-PCR  analysis  of  RNA  isolated  from 
peri-fracture site and cultured OBs. Total RNA was obtained from tis-
sues of peri-fracture site at day 7 or from cultured OBs using TRIzol (Life 
Technologies) according to the manufacturer’s instructions. After total RNA JEM VOL. 207, September 27, 2010 
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Mouse calvarial OB culture. Calvarial cells were isolated from 3–5-d-old 
mice using a modification of the method described by Wong and Cohn 
(1975). In brief, after removal of sutures, calvariae were subjected to four se-
quential 15-min digestions in an enzyme mixture containing 0.05% trypsin 
(Invitrogen) and 0.1% collagenase P (Boehringer Mannheim) at 37°C on a 
rocking platform. Cell fractions 2–4 were collected, and enzyme activity was 
stopped by the addition of an equal volume of DME containing 10% FCS, 
100 U/ml of penicillin, and 100 µg/ml of streptomycin (Invitrogen). The 
fractions were pooled, centrifuged, resuspended in DME containing 10% 
FCS, and filtered through a 70-µm cell strainer. Cells were plated at a density 
of 104 cells/well in 35-mm culture plates in DME containing 10% FCS. The 
medium was changed 24 h later, and 3 d later cultures were fed again. At 1 wk 
of culture, the medium was changed to a differentiation medium (-MEM 
containing 10% FCS, 50 µg/ml of ascorbic acid, and 4 mM of -glycero-
phosphate) and thereafter the medium was changed every 2 d. CFU-O was 
scored at day 7, 14, and 21 of incubation by in situ observation of plates on 
an inverted microscope. Effects of SCF and sKit on CFU-O formation and 
mineralization were also investigated in the above assay. Purified recombi-
nant human SCF and sKit were purchased from R&D Systems and supple-
mented concentrations of cytokines used for culture were as follows: SCF 
100 ng/ml and sKit 10 µg/ml (Nakamura, 2004).
Histochemical analysis of cell cultures. Histochemical staining for ALP 
was performed at day 7 and 14 using a commercially available kit (Muto-
Kagaku) according to the manufacturer’s instruction. Mineralization was as-
sessed using alizarin red staining method. In brief, the cultures were rinsed 
twice with PBS, fixed in 100% ethanol for 30 min, and stained wth 1% aliza-
rin red S (Hartman Leddon Co.) in 0.28% ammonia water for 10 min at 
room temperature. The stained cell layers were washed, rinsed twice with 
distilled water, and air-dried.
Matrix/intracellular calcium accumulation. Calcium content was   
measured by the orthocresolphthalein complexone (OCPC) colorimetric 
method (Sigma-Aldrich). In brief, cell layers at day 21 were washed with 
PBS twice, and then incubated with 50 µl of 0.6 N hydrochloric acid over-
night at room temperature. Plates were then vortexed and centrifuged 
for 20 min at 1,600 g at 25°C and 10 µl of sample was added to 100 µl 
OCPC solution in fresh wells. The plate was incubated at room temperature 
for 10 min, and then read at 575 nm. Standards were prepared from a CaCl2 
solution and the results were expressed in milligram/milliliter per 10,000 
seeded cells.
Statistical analysis. All values were expressed as mean ± SEM. Paired Stu-
dent’s t tests were performed for comparison of data before and after fracture. 
The comparisons among groups were made using the one-way analysis of 
variance. Post hoc analysis was performed by Fisher’s PLSD test. A p-value 
< 0.05 was considered to denote statistical significance.
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